Related Experiment Video

Updated: Aug 22, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

[Treatment protocol for long-term anti-epilepsy drugs in children with refractory epilepsy]

O Dulac1, C Chiron

  • 1Service du Pr Saudubray, Hôpital Necker, 149 Rue de Sèvres, 75015 Paris, France. o.dulac@nck.ap-hop-paris.fr

Revue Neurologique
|August 28, 2004
PubMed

Insights

Long-term treatment for drug-resistant epilepsy in children requires careful, periodic reassessment of surgical contraindications and medication choices. This includes verifying seizure characteristics and re-evaluating anti-epileptic drug dosages for optimal outcomes.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Clinical Therapeutics

Context:

  • Limited literature exists on long-term management of drug-resistant epilepsy in pediatric populations.
  • Surgical interventions for epilepsy necessitate ongoing evaluation of contraindications.
  • Current treatment paradigms may not adequately address the complexities of chronic pediatric epilepsy.

Purpose:

  • To highlight the need for detailed literature on long-term management strategies for drug-resistant epilepsy in children.
  • To emphasize the critical importance of periodic reassessment of surgical eligibility and treatment protocols.
  • To guide clinicians in optimizing anti-epileptic drug selection and dosage in pediatric epilepsy management.

Summary:

  • Long-term treatment of pediatric drug-resistant epilepsy demands periodic reassessment of surgical contraindications.
  • Verification of seizure nature, focal characteristics, and absence of surgical indicators (e.g., tumors, malformations) is crucial.
  • Anti-epileptic drug selection, tailored to epilepsy syndrome, and dosage adjustments, even post-callosotomy, require re-evaluation.

Impact:

  • Improved long-term outcomes for children with drug-resistant epilepsy.
  • Enhanced clinical decision-making regarding surgical interventions and pharmacotherapy.
  • Establishment of evidence-based guidelines for chronic pediatric epilepsy management.

More Related Videos

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice07:01

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study11:29

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study

Published on: August 15, 2025

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.